Tag: tissue microarray market analysis

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The tissue microarray sector has experienced swift expansion in recent years, driven by advancements in cancer research and diagnostic technologies. As the demand for more precise and efficient tissue analysis grows, this market is set to continue its strong upward trajectory. Below is an overview of the current market status, main growth drivers, segment breakdowns, major trends, competitive landscape, and regional outlook.

Rapid Expansion and Future Outlook of the Tissue Microarray Market

The tissue microarray market has demonstrated significant growth recently, with its size expected to increase from $13.11 billion in 2025 to $14.68 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.0%. This past growth stems from factors such as rising cancer research activities, broader use of immunohistochemistry techniques, growing academic pathology research, increased demand for biomarker validation tools, and the widespread availability of paraffin-embedded tissue samples. Looking ahead, the market is predicted to surge further, reaching $23.61 billion by 2030, with a slightly higher CAGR of 12.6%. The forecasted growth is largely supported by greater investment in precision oncology, wider adoption of digital pathology solutions, expansion in translational research initiatives, rising demand for multi-omics analysis, and increased utilization of tissue microarrays in drug discovery. Key trends shaping the market include the adoption of high-throughput tissue analysis platforms, multiplex immunohistochemistry, standardized tissue arrays, automated microarray construction, and integration with molecular diagnostics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

How the Demand for Personalized Medicine is Fueling Tissue Microarray Growth

One of the primary forces propelling the tissue microarray market is the growing emphasis on personalized medicine. This approach customizes medical treatments based on individual patient characteristics, making healthcare more targeted and effective. Tissue microarrays play a crucial role here by enabling rapid evaluation of multiple tissue samples simultaneously, which helps identify biomarkers essential for tailored therapies. To illustrate this trend, in February 2024, the Personalized Medicine Coalition—a US-based nonprofit—reported that the USFDA approved 16 new personalized treatments for rare diseases in 2023, a notable rise from just 6 in 2022. Such developments clearly indicate how the expanding personalized medicine landscape is boosting demand for tissue microarray technologies.

Segment Overview and Strategic Market Opportunities in Tissue Microarrays

This report categorizes the tissue microarray market into several key segments:

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization (FISH), Frozen Tissue Array, Other Types

2) By Technology: Immunohistochemistry (IHC)-Based Detection, In Situ Hybridization (ISH) Technologies, Digital Pathology and Image Analysis, Tissue Microarray Construction Technologies, Signal Detection and Visualization Technologies

3) By Application: Oncology Research and Biomarker Validation, Drug Discovery and Development, Translational and Clinical Research, Protein Expression and Localization Analysis, Gene and RNA Expression Analysis (Tissue-Based), Comparative Pathology and Toxicology Studies

4) By End-User: Pharmaceutical and Biotechnological Companies, Research Organizations, Hospitals

Further subcategories include:

– Immunohistochemistry: Automated, Manual, Multiplex

– Fluorescent In Situ Hybridization: Single-Color, Multi-Color, DNA FISH

– Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

– Other Types: RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

This segmentation highlights diverse market applications and technological approaches, offering strategic avenues for growth and specialization.

Access The Complete Tissue Microarray Market Report:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Industry Trends Driving Innovation and Growth in Tissue Microarrays

Leading players in the tissue microarray space are prioritizing the development of advanced platforms that enhance precision and throughput in tissue analysis. These microarray platforms enable the simultaneous examination of multiple genes or biomolecules on a compact surface, facilitating detailed genetic and expression studies. For example, in June 2023, MARGenomics—a research institute affiliated with Spain’s Hospital del Mar—introduced the Applied Biosystems GeneChip 3000 Dx v2. This cutting-edge microarray platform, supported by funding from the Carlos III Health Institute and the European Union’s NextGenerationEU program, became the first in both Europe and the US to receive regulatory approval for diagnostic use, including IVD-R certification. The system supports a broad range of functionalities, covering genomic and expression microarrays, reflecting the market’s push toward more integrated and powerful diagnostic tools.

Key Industry Players Influencing the Tissue Microarray Market

Several prominent companies are shaping competition within the tissue microarray market. These include BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co., 3DHISTECH Ltd., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, and iSpecimen Inc. These organizations are at the forefront of innovation, product development, and expanding market reach.

Regional Market Share and Growth Prospects of Tissue Microarrays

In 2025, North America commanded the largest share of the tissue microarray market, benefiting from substantial research infrastructure and healthcare investment. Meanwhile, the Asia-Pacific region is poised to be the fastest-growing market over the forecast period. The tissue microarray market report covers multiple regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global opportunities and dynamics.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Tissue Microarray Market Projected To Reach By 2030?

The tissue microarray market size has witnessed rapid expansion over recent years. Projections show it will increase from $13.11 billion in 2025 to $14.68 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.0%. The market’s growth during the preceding period was fueled by factors such as the rise in cancer research activities, the growing use of immunohistochemistry techniques, the development of academic pathology research, the increased requirement for biomarker validation tools, and the accessibility of paraffin-embedded tissue samples.

The tissue microarray market size is anticipated to experience substantial expansion in the coming years, with projections indicating it will reach $23.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. This expected growth throughout the forecast period stems from factors such as increasing investments in precision oncology research, the rising adoption of digital pathology solutions, the expansion of translational research initiatives, a growing demand for multi-omics analysis, and the increasing application of tissue microarrays in drug discovery. Prominent trends for this period include the wider use of high-throughput tissue analysis platforms, the rising acceptance of multiplex immunohistochemistry, an increasing demand for standardized tissue arrays, the expansion of automated tissue microarray construction, and enhanced integration with molecular diagnostics.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Which Drivers Are Supporting The Tissue Microarray Market Growth?

The increasing need for personalized medicine is projected to fuel the expansion of the tissue microarray market in the coming years. Personalized medicine involves customizing medical care based on individual traits, leading to more effective and accurate healthcare solutions. Tissue microarrays are employed in personalized medicine to simultaneously examine numerous tissue samples, enabling swift and effective biomarker evaluation for customized patient therapies. An example of this trend is seen in February 2024, when the USFDA gave approval to 16 new personalized treatments for individuals with rare diseases in 2023, as reported by the US-based nonprofit Personalized Medicine Coalition, which is a considerable rise from 6 such treatments in 2022. Consequently, the growing demand for personalized medicine is a key factor propelling the tissue microarray market’s development.

What Are The Key Segment Divisions In The Tissue Microarray Market Segment Structure?

The tissue microarray market covered in this report is segmented –

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

2) By Technology: Immunohistochemistry (IHC)–Based Detection, In Situ Hybridization (ISH) Technologies, Digital Pathology and Image Analysis, Tissue Microarray Construction Technologies, Signal Detection and Visualization Technologies

3) By Application: Oncology Research and Biomarker Validation, Drug Discovery and Development, Translational and Clinical Research, Protein Expression and Localization Analysis, Gene and RNA Expression Analysis (Tissue-Based), Comparative Pathology and Toxicology Studies

4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organizations, Hospitals

Subsegments:

1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

4) By Other Types: RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

Which Trends Are Expected To Impact The Tissue Microarray Market?

Companies prominent in the tissue microarray market are prioritizing sophisticated solutions, like microarray platforms, to improve the accuracy and effectiveness of high-volume tissue analysis. This technology enables the concurrent examination of numerous genes or other biomolecules on a compact area, aiding genetic and expression investigations. As an illustration, MARGenomics, a medical research institute from hospital del Mar in Spain, introduced the Applied Biosystems GeneChip 3000 Dx v2 in June 2023. This advanced microarray platform received funding from the Carlos III Health Institute (ISCIII) and the European Union’s NextGenerationEU initiative. Notably, it stands as the first microarray platform in both Europe and the United States to gain regulatory approval for diagnostic applications, having secured IVD-R (In Vitro Diagnosis Regulation) certification. The system offers a wide array of capabilities, including genomic and expression microarrays.

Which Organizations Are Engaged In The Tissue Microarray Market?

Major companies operating in the tissue microarray market are BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co., 3DHISTECH Ltd., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, iSpecimen Inc.

Get The Full Tissue Microarray Market Report:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Which Region Represents The Largest Share Of The Tissue Microarray Market?

North America was the largest region in the tissue microarray market in 2025. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Tissue Microarray Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Browse Through More Reports Similar to the Global Tissue Microarray Market 2026, By The Business Research Company

Microarray Market Report 2026

https://www.thebusinessresearchcompany.com/report/microarray-global-market-report

Dna Microarray Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-microarray-global-market-report

Microarray Scanners Market Report 2026

https://www.thebusinessresearchcompany.com/report/microarray-scanners-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Tissue Microarray Market At The End Of The 2026–2030 Forecast Period?

The tissue microarray market has witnessed substantial growth in recent years. Its valuation is anticipated to climb from $13.11 billion in 2025 to $14.68 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.0%. This historical expansion can be linked to factors such as an increase in cancer research efforts, the broader implementation of immunohistochemistry techniques, the development of academic pathology research, a growing need for biomarker validation tools, and the accessibility of paraffin-embedded tissue samples.

The tissue microarray market is projected to experience substantial expansion in the coming years, with its value expected to escalate to $23.61 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 12.6%. This anticipated growth during the forecast period is primarily driven by factors such as enhanced investment in precision oncology research, the increasing integration of digital pathology solutions, the proliferation of translational research initiatives, a rising need for multi-omics analysis, and the expanding application of tissue microarrays in the field of drug discovery. Key trends anticipated for this period encompass the greater utilization of high-throughput tissue analysis platforms, a growing embrace of multiplex immunohistochemistry, an escalating requirement for standardized tissue arrays, the broader implementation of automated tissue microarray construction, and improved incorporation with molecular diagnostics.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Tissue Microarray Market?

The increasing demand for personalized medicine is expected to stimulate the expansion of the tissue microarray market moving forward. Personalized medicine involves customizing medical treatment to an individual’s specific characteristics, aiming for more effective and precise healthcare outcomes. Within personalized medicine, tissue microarrays are utilized to concurrently analyze multiple tissue samples, allowing for the rapid and efficient assessment of biomarkers to guide tailored patient treatments. For instance, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the USFDA approved 16 new personalized treatments for rare disease patients in 2023, marking a significant increase from the 6 personalized treatments approved in 2022. Thus, the growing demand for personalized medicine is a key factor propelling the growth of the tissue microarray market.

What Segment Types Make Up The Tissue Microarray Market?

The tissue microarray market covered in this report is segmented –

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

2) By Technology: Immunohistochemistry (IHC)–Based Detection, In Situ Hybridization (ISH) Technologies, Digital Pathology and Image Analysis, Tissue Microarray Construction Technologies, Signal Detection and Visualization Technologies

3) By Application: Oncology Research and Biomarker Validation, Drug Discovery and Development, Translational and Clinical Research, Protein Expression and Localization Analysis, Gene and RNA Expression Analysis (Tissue-Based), Comparative Pathology and Toxicology Studies

4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organizations, Hospitals

Subsegments:

1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

4) By Other Types: RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

Which Market Trends Are Creating New Opportunities In The Tissue Microarray Market?

Major companies operating in the tissue microarray market are focusing on advanced solutions, such as microarray platforms, to enhance precision and efficiency in high-throughput tissue analysis. A microarray platform is a technology that facilitates simultaneous analysis of multiple genes or other biomolecules on a small surface, thereby enabling genetic and expression studies. For instance, in June 2023, MARGenomics, a Spain-based hospital del Mar medical research institute, launched the Applied Biosystems GeneChip 3000 Dx v2. This advanced microarray platform was funded by the Carlos III Health Institute (ISCIII) and the European Union’s NextGenerationEU initiative. It stands as the inaugural microarray platform in both Europe and the United States to receive regulatory approval for diagnostic purposes, having attained IVD-R (In Vitro Diagnosis Regulation) certification. The system boasts diverse functionalities, encompassing genomic and expression microarrays.

Who Are The Key Players Driving Competition In The Tissue Microarray Market?

Major companies operating in the tissue microarray market are BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co., 3DHISTECH Ltd., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, iSpecimen Inc.

Read the full tissue microarray market report here:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Which Regions Are Projected To Dominate The Tissue Microarray Market In The Coming Years?

North America was the largest region in the tissue microarray market in 2025. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Tissue Microarray Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

Browse Through More Reports Similar to the Global Tissue Microarray Market 2026, By The Business Research Company

Microarray Market Report 2026

https://www.thebusinessresearchcompany.com/report/microarray-global-market-report

Dna Microarray Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-microarray-global-market-report

Microarray Scanners Market Report 2026

https://www.thebusinessresearchcompany.com/report/microarray-scanners-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Tissue Microarray Market covering 2026–2035?

The tissue microarray market size has experienced rapid expansion in recent years. It is anticipated to grow from $13.11 billion in 2025 to $14.68 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.0%. This historical growth can be attributed to several factors, including escalating cancer research activities, the increased acceptance of immunohistochemistry techniques, the widening scope of academic pathology research, a surging demand for biomarker validation tools, and the ready availability of paraffin-embedded tissue samples.

The tissue microarray market size is anticipated to experience substantial growth over the next few years. Its valuation is projected to reach $23.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.6%. This projected increase during the forecast period is fueled by several factors, including greater funding for precision oncology research, the growing uptake of digital pathology solutions, the spread of translational research programs, rising demand for multi-omics analysis, and the expanding application of tissue microarrays in pharmaceutical development. Key developments anticipated within this timeframe involve the wider deployment of high-throughput tissue analysis platforms, increased use of multiplex immunohistochemistry, a growing need for standardized tissue arrays, the advancement of automated tissue microarray construction, and improved integration with molecular diagnostics.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Tissue Microarray Market?

The increasing need for personalized medicine is projected to fuel the expansion of the tissue microarray market moving ahead. This approach involves customizing medical care based on a person’s unique traits, leading to more effective and accurate health solutions. To achieve this, personalized medicine employs tissue microarrays, enabling the simultaneous analysis of numerous tissue samples. This facilitates the swift and effective evaluation of biomarkers, which in turn helps in developing customized treatments for patients. As an illustration, the Personalized Medicine Coalition, a US nonprofit organization, reported in February 2024 that the USFDA had approved 16 novel personalized therapies for individuals with rare diseases in 2023. This represents a substantial rise from the 6 personalized treatments approved in 2022. Consequently, the expanding demand for personalized medicine is a key factor propelling the growth of the tissue microarray market.

What Leading Segments Are Studied In The Tissue Microarray Market?

The tissue microarray market covered in this report is segmented –

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

2) By Technology: Immunohistochemistry (IHC)–Based Detection, In Situ Hybridization (ISH) Technologies, Digital Pathology and Image Analysis, Tissue Microarray Construction Technologies, Signal Detection and Visualization Technologies

3) By Application: Oncology Research and Biomarker Validation, Drug Discovery and Development, Translational and Clinical Research, Protein Expression and Localization Analysis, Gene and RNA Expression Analysis (Tissue-Based), Comparative Pathology and Toxicology Studies

4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organizations, Hospitals

Subsegments:

1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

4) By Other Types: RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

What Trends Are Driving The Growth Trajectory Of The Tissue Microarray Market?

Major companies engaged in the tissue microarray market are prioritizing advanced solutions, such as microarray platforms, to enhance precision and efficiency in high-throughput tissue analysis. A microarray platform represents a technology that allows for the concurrent analysis of numerous genes or other biomolecules on a compact surface, thereby facilitating genetic and expression studies. As an illustration, in June 2023, MARGenomics, a Spain-based hospital del Mar medical research institute, introduced the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform funded by the Carlos III Health Institute (ISCIII) and the European Union’s NextGenerationEU initiative. This platform is the first microarray system in both Europe and the United States to obtain regulatory clearance for diagnostic applications, having secured IVD-R (In Vitro Diagnosis Regulation) certification. The system offers diverse capabilities, including both genomic and expression microarrays.

Which Key Players Are Driving Competition In The Tissue Microarray Market?

Major companies operating in the tissue microarray market are BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co., 3DHISTECH Ltd., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, iSpecimen Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Which Region Currently Holds The Largest Share Of The Tissue Microarray Market?

North America was the largest region in the tissue microarray market in 2025. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Tissue Microarray Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

Browse Through More Reports Similar to the Global Tissue Microarray Market 2026, By The Business Research Company

Microarray Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/microarray-global-market-report

Dna Microarray Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dna-microarray-global-market-report

Microarray Scanners Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/microarray-scanners-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the tissue microarray market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The Tissue Microarray Industry By 2029?

The tissue microarray market has experienced robust expansion in recent years. This market is projected to increase from $12.05 billion in 2024 to $13.11 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.8%. Historically, this growth was primarily fueled by the advancement of precision medicine, innovations in drug discovery and development, the demand for efficient analysis, the increasing occurrence of chronic diseases, and various biobanking initiatives.

The tissue microarray market size is anticipated to experience substantial growth over the next few years. Its valuation is set to reach $20.85 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.3%. This expansion over the forecast period stems from the emergence of digital pathology, broader applications, the expanding biopharmaceutical sector, regulatory backing and established standards, along with the incorporation of AI and machine learning. Prominent trends expected during this period encompass advancements in imaging technologies, the development of 3D tissue microarrays, high-content screening methods, standardization efforts, and the integration of single-cell analysis.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

What Major Drivers Are Impacting The Tissue Microarray Market?

The increasing incidence of cancer is anticipated to fuel the expansion of the tissue microarray market in the future. Cancer refers to a group of diseases characterized by the uncontrolled proliferation of abnormal cells within any organ or tissue, which then transgress their normal limits and either spread to distant organs or infiltrate adjacent body regions. In oncology, tissue arrays serve to analyze the expression of biomarkers associated with cancer across diverse tumor specimens. For example, data released by Macmillan Cancer Support, a UK-based cancer charity, in June 2022 indicated that the population living with cancer reached 3 million in 2022 within the UK and is forecasted to climb to approximately 3.5 million by 2025 and 4 million by 2030. Consequently, the rising prevalence of cancer cases is stimulating the growth of the tissue microarray market.

Which Segment Categories Are Driving Maximum Growth In The Tissue Microarray Market?

The tissue microarraymarket covered in this report is segmented –

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

Subsegments:

1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

Which Long-Term Trends Will Play A Crucial Role In The Tissue Microarray Market?

A significant development gaining traction within the tissue microarray market involves strategic partnerships. Prominent entities within the tissue microarray sector are engaging in collaborations to cultivate new relationships, leading to the joint advancement of tissue microarray technologies by two or more organizations. For example, in November 2022, The Cureline Group, a US-based CRO specializing in translational and precision medicine, which offers HBS biobanking and laboratory services, collaborated with Cellecta Inc., a US-based supplier of RNAi and CRISPR screening solutions. This partnership resulted in the introduction of Tissue 2 Target Services, a new strategic alliance designed to merge their respective core competencies in the molecular analysis of cells and tissues with human biospecimen management. The objective is to provide pre-clinical and translational research facilities focused on gene target and biomarker discovery services, thus optimizing workflows. Additionally, in September 2022, Ultivue Inc., a US-based biotechnology firm that develops reagent-based solutions to maximize biological information from cells and tissue samples, formed a partnership with ngTMA, a Switzerland-based Translational Research Unit (TRU) platform associated with the University of Bern, which innovates workflows for tissue microarray construction. This alliance intends to advance multiplexed immunofluorescence (mIF) assays and implement new TMA technologies to unlock spatial analysis in scientific research, thereby enhancing the quality of TMAs utilized in clinical and translational studies.

Who Are The Dominant Players In The Tissue Microarray Market Today?

Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Which Region Is At The Forefront Of Innovation In The Tissue Microarray Market?

North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

Browse Through More Reports Similar to the Global Tissue Microarray Market 2025, By The Business Research Company

Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report

Computer Peripheral Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computer-peripheral-equipment-global-market-report

Computed Tomography Ct Scanners Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computed-tomography-ct-scanners-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Tissue Microarray Industry In 2025?

The overall valuation of the tissue microarray sector has seen considerable growth over the past few years, with projections indicating an expansion from USD 12.05 billion in 2024 to USD 13.11 billion by the following year, reflecting an 8.8% compound annual growth rate; this positive trajectory during the historical period is largely fueled by the increasing adoption of personalized medicine approaches, vigorous drug research and development activities, the demand for more streamlined analytical processes, the escalating incidence of long-term illnesses, and the expansion of biobanking efforts worldwide.

The tissue microarray sector anticipates a swift expansion in the coming years, projecting a valuation of $20.85 billion by 2029, fueled by a compound annual growth rate (CAGR) reaching 12.3 percent. This trajectory throughout the projection timeframe is powered by the rise of digital pathology, broader utilization across various fields, the expansion of the biopharmaceutical sector, the establishment of regulatory endorsements and uniform guidelines, and the incorporation of artificial intelligence alongside machine learning. Key movements defining this period involve innovations in visual data capture methods, the creation of three-dimensional tissue microarrays, implementation of high-content screening protocols, efforts aimed at establishing industry standards, and the integration of single-cell analysis techniques.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

Which Major Market Drivers Are Shaping The Future Of The Tissue Microarray Market?

Anticipated escalation in cancer prevalence is set to fuel the expansion of the tissue microarray sector moving ahead. This disease category, characterized by the uncontrolled multiplication of abnormal cells that breach normal limitations and subsequently infiltrate adjacent structures or disseminate to distant sites, can manifest in any bodily organ or tissue. In the field of oncology, tissue arrays serve as vital tools for assessing the presence of cancer-relevant biomarkers across diverse tumor specimens. To illustrate this trend, data released in June 2022 by Macmillan Cancer Support, a charitable organization in the UK focusing on cancer, indicated that the population afflicted by cancer reached 3 million in that year, with forecasts suggesting this figure will climb towards 3.5 million by 2025 and further to 4 million by the close of 2030 within the United Kingdom; consequently, this increasing incidence of cancer constitutes a primary impetus behind the market growth for tissue microarrays.

What Are The Major Segment Types Covered In The Tissue Microarray Market?

The tissue microarraymarket covered in this report is segmented –

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

Subsegments:

1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

What Key Innovation Trends Are Fueling Advancements In The Tissue Microarray Market?

A significant and escalating trend within the arena of tissue microarray technology involves forging strategic alliances, wherein numerous prominent entities within this sector are actively engaging in collaborations designed to pioneer novel tissue microarray advancements through joint efforts. Illustratively, in November of 2022, The Cureline Group, a United States-based contract research organization specializing in precision and translational medicine, offering laboratory and HBS biobanking support, entered into a collaborative agreement with Cellecta Inc., an American firm supplying both RNAi and CRISPR screening products and associated services; this union established the Tissue 2 Target Services, a fresh strategic compact intended to meld the core proficiencies of both organizations in the domain of molecular analysis concerning cells and tissues alongside human biospecimen stewardship, ultimately furnishing pre-clinical and translational research operations with specialized gene target and biomarker identification capabilities designed for streamlined operational processes. Adding to this, a separate development occurred in September 2022 when Ultivue Inc., an American biotechnology company focused on creating reagent-driven solutions that maximize the biological insights extracted from tissue and cellular specimens, linked up with ngTMA, which operates as the Translational Research Unit platform based in Switzerland for the University of Bern and concentrates on innovating tissue microarray fabrication workflows; the objective of this specific partnership is to propel multiplexed immunofluorescence (mIF) assays forward and integrate emerging TMA methodologies to facilitate spatial analysis in scientific investigations, thereby elevating the standard of TMAs utilized presently in both clinical and translational research settings.

Which Key Players Are Driving Competition In The Tissue Microarray Market?

Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

What Regional Growth Trends Are Shaping The Tissue Microarray Market Outlook?

North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Tissue Microarray Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

Browse Through More Reports Similar to the Global Tissue Microarray Market 2025, By The Business Research Company

Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report

Computer Peripheral Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computer-peripheral-equipment-global-market-report

Computed Tomography Ct Scanners Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computed-tomography-ct-scanners-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Tissue Microarray Market Be Worth By 2029?

There has been a robust expansion in the market size of tissue microarray in the past few years. The market, valued at $12.05 billion in 2024, is expected to increase to $13.11 billion by 2025, with a compound annual growth rate (CAGR) of 8.8%. The significant growth during the historic period can be linked to advancements such as precision medicine, drug discovery and development, efficient analysis, and increasing cases of chronic illnesses, along with initiatives in biobanking.

The market for tissue microarray is predicted to undergo quick expansion in the upcoming years. It’s projected to rise to $20.85 billion in 2029 with a compound annual growth rate (CAGR) of 12.3%. Factors such as the introduction of digital pathology, broadened applications, expansion of the biopharmaceutical industry, regulatory backing and standards, and the integration of AI and machine learning contribute to this growth in the forecast period. Major trends expected to shape the market during this period include progress in imaging technologies, the creation of 3D tissue microarrays, high-content screening, initiatives for standardization, and the incorporation of single-cell analysis.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

Which Key Factors Are Fueling Growth In The Tissue Microarray Market?

The escalating count of cancer incidents is anticipated to fuel the expansion of the tissue microarray market in the future. Cancer refers to a class of diseases that can emerge in any body’s organ or tissue when abnormal cells multiply without control, overstep their normal limits, and either metastasize to other organs or infiltrate adjacent parts of the body. Tissue arrays play a critical role in oncology by scrutinizing the expression of cancer-related biomarkers in diverse tumor specimens. As an example, the data released by the Macmillan Cancer Support, a cancer charity based in the UK, showed that the population of people battling cancer reached 3 million in 2022 in June. This figure is forecasted to surge to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Hence, the increasing count of cancer incidents is steering the expansion of the tissue microarray market.

Which Segmentation Factors Are Critical In The Tissue Microarray Market Analysis?

The tissue microarraymarket covered in this report is segmented –

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

Subsegments:

1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

What Are The Dominant Trends Currently Seen In The Tissue Microarray Market?

The rising trend of strategic alliances is significantly impacting the tissue microarray market. Many leading firms in this market are entering into partnerships to foster collaborative development of tissue microarray technologies. For example, in November 2022, The Cureline Group, a firm based in the US that provides translational and precision medicine CRO services, including HBS biobanking and laboratory services, formed a partnership with Cellecta Inc., also a US-based firm that specializes in RNAi and CRISPR screening products and services. This partnership led to the launch of Tissue 2 Target Services, an innovative strategic collaboration that amalgamates both companies’ key strengths in cellular and tissue molecular analysis and human biospecimen management, thereby offering facilities for pre-clinical and translational research that specialize in gene target and biomarker discovery services and facilitate more streamlined workflows. Additionally, in September 2022, Ultivue Inc., a US-based biotech firm that offers reagent-based solutions for maximizing the biological information obtainable from tissue and cell samples, entered into a collaboration with the Switzerland-based Translational Research Unit (TRU) platform ngTMA from the University of Bern, known for their innovative tissue microarray construction workflows. The goal of this collaboration is to enhance mIF assays and to implement novel TMA technologies to enable more effective spatial analysis in scientific research, while also improving the quality of TMAs used in both clinical and translational research.

Which Players Are Shaping The Competitive Landscape Of The Tissue Microarray Market?

Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Tissue Microarray Market?

North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

Browse Through More Reports Similar to the Global Tissue Microarray Market 2025, By The Business Research Company

Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report

Computer Peripheral Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computer-peripheral-equipment-global-market-report

Computed Tomography Ct Scanners Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computed-tomography-ct-scanners-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Tissue Microarray Market Size Changed, over the years?

The size of the tissue microarray market has seen considerable growth in the past few years. It is forecasted to expand from $12.05 billion in 2024 to $13.23 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. The growth during the historical period can be associated with the emergence of precision medicine, advancements in drug discovery and development, efficient analysis, an increase in chronic diseases, and biobanking initiatives.

How Much Will the Tissue Microarray Market Be Worth in 2029?

In the upcoming years, the tissue microarray market is anticipated to witness a significant growth in its size. With a compound annual growth rate of 12.2%, it’s projected to reach $20.95 billion by 2029. The expected growth during the forecast period is due to factors such as the advent of digital pathology, increased applications, the expansion of the biopharmaceutical industry, regulatory reinforcement and standards, as well as the integration of AI and machine learning. Key trends for the forecast period include advances in imaging technologies, the creation of 3D tissue microarrays, high-content screening, initiatives for standardization, and the incorporation of single-cell analysis.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

Which is the Largest Company in the Tissue Microarray Market?

Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

What Are the Main Market Drivers in the Tissue Microarray Industry?

As the incidence of cancer continues to rise, so is the anticipated expansion of the tissue microarray market. Cancer, a broad spectrum of diseases that occurs when cells grow out of control, break through their natural boundaries, and invade other organs or neighboring tissues, is profoundly affecting any organ or tissue in the body. Tissue arrays play a critical role in oncology by facilitating the analysis of cancer-related biomarkers in diverse tumor specimens. In June 2022, reports from the British cancer charity, Macmillan Cancer Support, indicated that the number of cancer patients had reached 3 million in 2022 and is predicted to soar close to 3.5 million by 2025 and 4 million by 2030, specifically in the UK. Thus, the increasing prevalence of cancer is fueling the upward trajectory of the tissue microarray market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

How Is the Tissue Microarray Market Segments Structured?

The tissue microarray market covered in this report is segmented –

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

Subsegments:

1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

What Strategic Trends Are Transforming the Tissue Microarray Market?

Forming strategic alliances is becoming increasingly popular in the tissue microarray industry. Companies in this field are entering partnerships to forge new relations for the development of tissue microarray technologies. For instance, in November 2022, The Cureline Group, an American CRO specializing in translational and precision medicine, providing HBS biobanking and lab services, collaborated with Cellecta Inc., an American firm offering RNAi and CRISPR screening products and services. The partnership, called Tissue 2 Target Services, combines the companies’ crucial skills in molecular analysis of cells and tissue and human biospecimen management. Their goal is to provide pre-clinical and translational research facilities that specialize in gene target and biomarker discovery services to optimize workflows. Moreover, in September 2022, a strategic collaboration was initiated between Ultivue Inc., an American biotech company that creates reagent-based solutions for maximizing the biological data from cells and tissue samples, and ngTMA, a TRU platform originating from the University of Bern in Switzerland that designs innovative workflows for tissue microarray construction. The objective of this collaboration is to improve multiplexed immunofluorescence (mIF) assays, employ new TMA technologies for spatial analysis in scientific research, and upgrade the quality of TMAs used in clinical and translational research.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

Which Global Regions Offer the Highest Growth in the Tissue Microarray Market?

North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12236

This Report Delivers Insight On:

1. How big is the tissue microarray market, and how is it changing globally?

2. Who are the major companies in the tissue microarray market, and how are they performing?

3. What are the key opportunities and risks in the tissue microarray market right now?

4. Which products or customer segments are growing the most in the tissue microarray market?

5. What factors are helping or slowing down the growth of the tissue microarray market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the tissue microarray industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has the Tissue Microarray Market Growth Performance Trended Historically, And What Lies Ahead?

The size of the tissue microarray market has seen considerable growth in the past few years. It is forecasted to expand from $12.05 billion in 2024 to $13.23 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. The growth during the historical period can be associated with the emergence of precision medicine, advancements in drug discovery and development, efficient analysis, an increase in chronic diseases, and biobanking initiatives.

In the upcoming years, the tissue microarray market is anticipated to witness a significant growth in its size. With a compound annual growth rate of 12.2%, it’s projected to reach $20.95 billion by 2029. The expected growth during the forecast period is due to factors such as the advent of digital pathology, increased applications, the expansion of the biopharmaceutical industry, regulatory reinforcement and standards, as well as the integration of AI and machine learning. Key trends for the forecast period include advances in imaging technologies, the creation of 3D tissue microarrays, high-content screening, initiatives for standardization, and the incorporation of single-cell analysis.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Tissue Microarray Market?

As the incidence of cancer continues to rise, so is the anticipated expansion of the tissue microarray market. Cancer, a broad spectrum of diseases that occurs when cells grow out of control, break through their natural boundaries, and invade other organs or neighboring tissues, is profoundly affecting any organ or tissue in the body. Tissue arrays play a critical role in oncology by facilitating the analysis of cancer-related biomarkers in diverse tumor specimens. In June 2022, reports from the British cancer charity, Macmillan Cancer Support, indicated that the number of cancer patients had reached 3 million in 2022 and is predicted to soar close to 3.5 million by 2025 and 4 million by 2030, specifically in the UK. Thus, the increasing prevalence of cancer is fueling the upward trajectory of the tissue microarray market.

Which Primary Segments of the Tissue Microarray Market Are Driving Growth and Industry Transformations?

The tissue microarray market covered in this report is segmented –

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

Subsegments:

1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Tissue Microarray Market?# Market?

North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Tissue Microarray Market?

Forming strategic alliances is becoming increasingly popular in the tissue microarray industry. Companies in this field are entering partnerships to forge new relations for the development of tissue microarray technologies. For instance, in November 2022, The Cureline Group, an American CRO specializing in translational and precision medicine, providing HBS biobanking and lab services, collaborated with Cellecta Inc., an American firm offering RNAi and CRISPR screening products and services. The partnership, called Tissue 2 Target Services, combines the companies’ crucial skills in molecular analysis of cells and tissue and human biospecimen management. Their goal is to provide pre-clinical and translational research facilities that specialize in gene target and biomarker discovery services to optimize workflows. Moreover, in September 2022, a strategic collaboration was initiated between Ultivue Inc., an American biotech company that creates reagent-based solutions for maximizing the biological data from cells and tissue samples, and ngTMA, a TRU platform originating from the University of Bern in Switzerland that designs innovative workflows for tissue microarray construction. The objective of this collaboration is to improve multiplexed immunofluorescence (mIF) assays, employ new TMA technologies for spatial analysis in scientific research, and upgrade the quality of TMAs used in clinical and translational research.

View the full report here:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

What Parameters Are Used to Define the Tissue Microarray Market?

Tissue microarray refers to high-throughput technology that enables thorough analysis of an antigen’s expression across numerous tissues and cells in a single experiment using paraffin blocks or formalin. Tissue microarrays are used to simultaneously assess the protein expression of multiple tissue samples.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12236

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model